Scientists reprogram Kids' own cells to hunt liver cancer
NCT ID NCT02932956
Summary
This early-stage study is testing a new treatment called GAP T cells in children and young adults with liver cancer that has come back or hasn't responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to recognize and attack cancer cells, and then infuse them back into the patient. The main goals are to find the safest dose, see how long the cells last, and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.